JP2014500265A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500265A5
JP2014500265A5 JP2013542244A JP2013542244A JP2014500265A5 JP 2014500265 A5 JP2014500265 A5 JP 2014500265A5 JP 2013542244 A JP2013542244 A JP 2013542244A JP 2013542244 A JP2013542244 A JP 2013542244A JP 2014500265 A5 JP2014500265 A5 JP 2014500265A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
hydroxy
same
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014500265A (ja
JP6093307B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/063295 external-priority patent/WO2012075494A1/en
Publication of JP2014500265A publication Critical patent/JP2014500265A/ja
Publication of JP2014500265A5 publication Critical patent/JP2014500265A5/ja
Application granted granted Critical
Publication of JP6093307B2 publication Critical patent/JP6093307B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542244A 2010-12-03 2011-12-05 ウイルス感染の治療および予防のための新規シクロスポリン誘導体 Expired - Fee Related JP6093307B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41932610P 2010-12-03 2010-12-03
US61/419,326 2010-12-03
PCT/US2011/063295 WO2012075494A1 (en) 2010-12-03 2011-12-05 Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Publications (3)

Publication Number Publication Date
JP2014500265A JP2014500265A (ja) 2014-01-09
JP2014500265A5 true JP2014500265A5 (enExample) 2015-02-05
JP6093307B2 JP6093307B2 (ja) 2017-03-08

Family

ID=46172312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542244A Expired - Fee Related JP6093307B2 (ja) 2010-12-03 2011-12-05 ウイルス感染の治療および予防のための新規シクロスポリン誘導体

Country Status (13)

Country Link
EP (1) EP2646043B1 (enExample)
JP (1) JP6093307B2 (enExample)
CN (1) CN103249424B (enExample)
AU (1) AU2011336266B2 (enExample)
BR (1) BR112013015771A2 (enExample)
CA (1) CA2819608C (enExample)
DK (1) DK2646043T3 (enExample)
ES (1) ES2625502T3 (enExample)
MX (1) MX350746B (enExample)
PT (1) PT2646043T (enExample)
RU (1) RU2601742C2 (enExample)
WO (1) WO2012075494A1 (enExample)
ZA (1) ZA201303610B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
CN103153330B (zh) 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
AU2011316690C1 (en) 2010-10-12 2017-01-19 Allergan, Inc. Cyclosporin analogs
EP2627663B1 (en) 2010-10-12 2018-02-21 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
WO2013181339A2 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
WO2014049540A2 (en) 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
BR112015023669A2 (pt) * 2013-03-15 2017-07-18 Yang Suizhou novos derivados de ciclosporina e suas utilizações
TW201639873A (zh) 2015-01-08 2016-11-16 歐樂根公司 Mebmt側鏈已環化之環孢菌素衍生物
AU2017267560B2 (en) 2016-05-17 2022-03-24 S&T Global Inc. Novel cyclosporin derivatives and uses thereof
ES3025233T3 (en) 2019-01-24 2025-06-06 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3686252A1 (en) 2019-01-24 2020-07-29 Agfa-Gevaert Nv Radiation curable inkjet ink for manufacturing printed circuit boards
CA3128410A1 (en) 2019-10-11 2021-04-15 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Ws-635 uses thereof in medicine
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
EP4161557B1 (en) * 2020-06-04 2026-03-11 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Ws-635 for use in the treatment or prevention of sars-cov-2 infection
WO2026119135A1 (en) * 2024-12-03 2026-06-11 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
CN1141317C (zh) * 1995-07-17 2004-03-10 碳化学公司 有抗人体免疫缺损病毒作用的环孢菌素衍生物
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
PT1802650E (pt) * 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
CN101068829B (zh) * 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
US7196161B2 (en) * 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
KR20110116136A (ko) * 2009-01-07 2011-10-25 싸이넥시스, 인크. Hcv 및 hiv 감염의 치료에 사용하기 위한 사이클로스포린 유도체
RU2492181C2 (ru) * 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
CN103153330B (zh) * 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用

Similar Documents

Publication Publication Date Title
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
JP2016506962A5 (enExample)
JP2013537203A5 (enExample)
JP2019500387A5 (enExample)
JP2008514732A5 (enExample)
JP2021512150A5 (enExample)
JP2017537940A5 (enExample)
JP2016506960A5 (enExample)
JP2010031025A5 (enExample)
JP2017528467A5 (enExample)
JP2011513410A5 (enExample)
JP2013545785A5 (enExample)
JP2015523383A5 (enExample)
JP2014511891A5 (enExample)
JP2011529502A5 (enExample)
JP2014503525A5 (enExample)
JP2014511892A5 (enExample)
HRP20241540T1 (hr) Pirolotriazinski spojevi koji djeluju kao inhibitor mnk
JP2017504635A5 (enExample)
JP2011516610A5 (enExample)
JP2007191486A5 (enExample)
JP2016506961A5 (enExample)
JP2010501584A5 (enExample)
JP2008509166A5 (enExample)
JP2016505586A5 (enExample)